White Cheddar 5906-KD is a non-GMO White Cheddar Cheese Blend dried cheese powder. Product was shipped in bulk bags, net wt 50 lbs. Th...
⚠ Critical Alert — Stop Using Immediately
This product has been flagged with severe risks (Salmonella contamination). Stop using it now and contact the brand or FDA for a refund, repair, or replacement.
FDA Recall Notice
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1557-2019.
White Cheddar Blend is recalled due to a potential contamination with Salmonella.
Corrective Action (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1557-2019.
Recall terminated by FDA.
✅ What you should do
- Stop using the product if you own it.
- Check the model number, lot code, or sell-by date against the recall notice above.
- Contact Commercial Creamery Company Of Idaho, Inc. or the retailer where you bought it for a refund, replacement, or repair.
- For the most current official instructions, visit the FDA recall page.
- If you've been hurt by this product, report the incident to FDA.
Consumer Contact (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1557-2019.
Commercial Creamery Company of Idaho, Inc.
About the U.S. Food and Drug Administration
The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.
Visit FDA.gov →📣 Report a food, supplement, or cosmetic problem to the FDA
If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.
Commercial Creamery Company Of Idaho, Inc. Recall FAQ
Commercial Creamery Company Of Idaho, Inc. is the subject of a dairy safety report: White Cheddar 5906-KD is a non-GMO White Cheddar Cheese Blend dried cheese powder. Product was shipped in bulk bags, net wt 50 lbs. Th.... The notice was published on June 24, 2019 by the U.S. Food and Drug Administration (FDA). Approximately 2,000 units are potentially affected.